Excimer Laser Trabeculostomy for Glaucoma

(ELTGTS Trial)

Recruiting at 20 trial locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: ELT Sight, Inc

No Placebo Group

Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This trial evaluates the safety and effectiveness of the ELIOS System, a procedure to lower eye pressure, in adults with mild to moderate primary open-angle glaucoma who are undergoing cataract surgery.

Research Team

Iqbal (Ike) Ahmed, MD

Principal Investigator

Prism Eye Institute

Eligibility Criteria

Adults over 45 with mild to moderate primary open-angle glaucoma and cataracts can join this trial. They must have specific intraocular pressure levels, a certain angle in their eye's drainage area, and no past major eye surgeries. Pregnant or nursing women and those not using birth control are excluded.

Inclusion Criteria

My eye pressure is 24 mmHg or less with medication.

CD ratio <=0.8

Unmedicated diurnal IOP of >=22 mmHg and <=34 mmHg

Exclusion Criteria

I have been diagnosed with a condition that is causing my vision to worsen over time.

Non-study eye with BCVA worse than 20/80

Known corticosteroid responder

Treatment Details

Interventions

• ELIOS Procedure (Excimer Laser)

Trial Overview The ELIOS System procedure is being tested for its ability to lower the pressure inside the eye when combined with cataract surgery in adults with open-angle glaucoma. The study aims to assess both safety and effectiveness of this treatment.

Participant Groups

Group I: ELIOS Procedure Experimental Treatment 1 Intervention

ELIOS Procedure

Who Is Running the Clinical Trial?

ELT Sight, Inc

Lead Sponsor

Trials

1

Recruited

320+

Elios Vision, Inc.

Lead Sponsor

Trials

3

Recruited

580+